Carisoprodol Tablets
Failed Impurity/degradation Specification
Most common reason: Particulate / foreign matter (4 of these recalls)
Recalls are matched by product description. A recall usually affects specific lots, not every package of Carisoprodol. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Failed Impurity/degradation Specification
Presence of Foreign Substance; metal particulates were visually observed in the tablets.
Presence of Foreign Substance; heavy metals (chromium, titanium etc) and inactive components of the product were visually observed during routine stability testing.
Presence of Foreign Substance; heavy metals (chromium, titanium etc) and inactive components of the product were visually observed during routine stability testing
Presence of Foreign Substance: Uncharacteristic blacks spots on tablets.
Labeling: Not elsewhere classified: On 12/12/11, DEA published a final rule in the Federal Register making this product a schedule IV (C-IV)controlled substance. This product is being recalled because this controlled product was not relabeled with the required "C-IV" imprint on the label for products distributed after the 06/11/12 deadline.
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.